SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001104659-19-076768
Filing Date
2019-12-30
Accepted
2019-12-30 16:00:54
Documents
5
Group Members
SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D tm1927372-1_sc13d.htm SC 13D 74703
2 EXHIBIT 99.1 tm1927372d1_ex99-1.htm EX-99.1 4181
3 EXHIBIT 99.2 tm1927372d1_ex99-2.htm EX-99.2 21081
4 EXHIBIT 99.4 tm1927372d1_ex99-4.htm EX-99.4 73299
5 EXHIBIT 99.5 tm1927372d1_ex99-5.htm EX-99.5 56431
  Complete submission text file 0001104659-19-076768.txt   231417
Mailing Address FLAT/ROOM 808 ICBC TOWER, 3 GARDEN ROAD HONG KONG F4 00000
Business Address FLAT/ROOM 808 ICBC TOWER, 3 GARDEN ROAD HONG KONG F4 00000 021-63321633
Fosun Industrial Co., Ltd (Filed by) CIK: 0001448032 (see all company filings)

IRS No.: 000000000 | State of Incorp.: F4 | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 23RD FLOOR, 299 QRC 287-299 QUEEN'S ROAD CENTRAL HONG KONG K3 00000
Business Address 23RD FLOOR, 299 QRC 287-299 QUEEN'S ROAD CENTRAL HONG KONG K3 00000 852-6491-9230
New Frontier Health Corp (Subject) CIK: 0001737422 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-90555 | Film No.: 191316657
SIC: 6770 Blank Checks